To compare the effects of long-term treatment with (ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) or another (ultra-)long-acting insulin analogue in people with type 1 diabetes mellitus.
This is a protocol.
(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus
You may also be interested in:
- (Ultra-)long-acting insulin analogues compared with NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
- Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus
- Definitions and reporting of hypoglycaemia in trials of long-acting insulin analogues in people with type 1 diabetes mellitus
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
- Hormone replacement therapy for women with type 1 diabetes mellitus
Health topics: